Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides

Vaccine

Volumn 14, Issue 5, 1996, Pages 412-418

  Hioe, Catarina E ^a   Qiu, Howard ^b   Chend, Pei De ^b   Bian, Zuning ^b   Li, Ming Lie ^b   Li, Joseph ^b   Singh, Manmohan ^b   Kuebler, Peter ^b   McGee, Paul ^b   O'Hagan, Derek ^b   Zamb, Tim ^b   Koff, Wayne ^b   Allsopp, Catherine ^c   Wang, Chang Yi ^b   Nixon, Douglas F ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b United Biomedical Inc   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adjuvant; Circumsporozoite; Cytotoxic T lymphocyte; Plasmodium berghei

Indexed keywords

ANTIGEN; EPITOPE; IMMUNOLOGICAL ADJUVANT; LIPOPEPTIDE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SOYBEAN;

EID: 0029898025     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00191-3     Document Type: Article

References (37)

1. Rouse, B.T., Norley, S. and Martin, S. Antiviral cytotoxic T lymphocyte induction and vaccination. Rev. Infect. bis. 1988, 10, 16-33
2. Melief, C.J. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 1992, 58, 143-175
3. Golovliov, I., Ericsson, M., Åkerblom, L., Sandström, G., Tärnvik, A, and Sjöstedt, A. Adjuvanticity of ISCOMs incorporating a T cell reactive lipoprotein of facultative intracellular pathogen Francisella turalensis. Vaccine 1995, 13, 261-267
4. Lipford, G.B., Wagner, H. and Heeg, K. Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 1994, 12, 73-80
5. Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N. and Berzofsky, J.A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 1990, 344, 873-875
6. Zhou, F., Rouse, B.T. and Huang, L. Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J. Immunol. 1992, 149, 599-604
7. Ulmer, J.B., Donnelly, J.J., Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749
8. Hruby, D.E. Vaccinia virus vectors: new strategies for producing recombinant vaccines. Clin. Microbiol. Rev. 1990, 3, 53-170
9. Lowe, R.S., Keller, P.M., Keech, B.J. et al. Varicella-zoster virus as a live vector for the expression of foreign genes. Proc. Natl Acad. Sci. USA 1987, 84, 3896-3900
10. Aichele, P., Hengartner, H., Zinkernagel, R.M. and Schulz, M. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 1990, 171, 1815-1820
11. Kast, W.M., Roux, L., Curren, J. et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl Acad. Sci. USA 1991, 88, 2293-2297
12. Zhou, X., Motal, U.M.A., Berg, L. and Jondal, M. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur. J. Immunol. 1992, 22, 3085-3090
13. Scalzo, A.A., Elliott, S.L., Cox, J., Gardner, J., Moss, D.J. and Suhrbier, A. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J. Virol. 1995, 69, 1306-1309
14. Newman, M.J., Wu, J.-Y., Gardner, B.H. et al. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses. J. Immunol. 1992, 148, 2357-2363
15. Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G. and Rammensee, H.-G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989, 342, 561-564
16. Martinon, F., Gras-Masse, H., Boutillon, C. et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J. Immunol. 1992, 149, 3416-3422
17. Borges, E., Wiesmüller, K.-H., Jung, G. and Walden, P. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J. Immunol. Meth. 1994, 173, 253-263
18. Bourgault, I., Chirat, F., Tartar, A., Lévy, J.-P., Guillet, J.G. and Venet, A. Simian immunodeficiency virus as a model for vaccination against HIV Induction in rhesus macaques of GAG-or NEF-specific cytotoxic T lymphocytes by lipopeptides. J. Immunol. 1994, 152, 2530-2537
19. Vitiello, A., Ishioka, G., Grey, H.M. et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J. Clin. Invest. 1995, 95, 341-349
20. Romero, P., Maryanski, J.L., Cordey, A.-S., Corradin, G., Nussenzweig, R.S. and Zavala, F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341, 323-326
21. d restricted antigenic peptides share a simple binding motif. J. Exp. Med. 1991, 174, 603-612
22. Kleine, B., Rapp, W., Wiesmüller, K.-H. et al. Lipopeptide-polyoxyethylene conjugates as mitogens and adjuvants. Immunobiology 1994, 190, 53-66
23. ™ emulsions. Biochim. Biophys. Acta 1991, 1086, 265-272
24. d molecule affect CTL recognition and binding of the nucleoprotein peptide from lymphocytic choriomeningitis virus. Immunogenetics 1994, 40, 222-229
25. Stieneker, F., Kersten, G., van Bloois, L. et al. Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. Vaccine 1995, 13, 45-53
26. Bui, T., Dykers, T., Hu, S.L., Faltynek, C.R. and Ho, R.J. Effect of MTP-PE liposomes and interleukin-7 on induction of antibody and cell-mediated immune responses to a recombinant HIV-envelope protein. J. AIDS 1994, 7, 799-806
27. Layton, G.T., Harris, S.J., Gearing, A.J.H. et al. HIV-1 V3 loop-specific CTLs are primed in vivo using hybrid V3:Ty-VLPs. In: Vaccines93: Modern Approaches to New Vaccines including Prevention of AIDS (Eds Ginsberg, H.S., Brown, F., Chanock, R.M. and Lerner, R.A.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1993, pp. 85-90
28. Wu, J.-Y., Gardner, B.H., Murphy, C.I. et al. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 1992, 148, 1519-1525
29. Collins, W.E., Pye, D., Crewther, P.E. et al. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. Am. J. Trop. Med. Hyg. 1994, 51, 711-719
30. Kahn, J.O. and Birx, D.L. Vaccines directed against HIV: preventive and therapeutic strategies. AIDS Clin. Rev. 1993, 94, 213-238
31. Edelman, R. An update on vaccine adjuvants in clinical trial. AIDS Res. Hum. Retrovir. 1992, 8, 1409-1411
32. Romero, P., Tam, J., Schlesinger, D. et al. Multiple T-helper cell epitopes of the circumsporozoite protein of Plasmodium berghei. Eur. J. Immunol. 1988, 18, 1951-1956
33. Schild, H., Deres, K., Wiesmüller, K.-H., Jung, G. and Rammensee, H.-G. Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. Eur. J. Immunol. 1991, 21, 2649-2654
34. Widmann, C., Romero, P., Maryanski, J.L., Corradin, G. and Valmori, D. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J. Immunol. Meth. 1992, 155, 95-99
35. Valmori, D., Romero, J.F., Men, Y., Maryanski, J.L., Romero, P. and Corradin, G. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 1994, 24, 1458-1462
36. Wiedemann, F., Link, R., Pumpe, K. et al. Histopathological studies on the local reactions induced by complete Freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates. J. Pathol. 1991, 164, 265-271
37. Hauschildt, S. Hoffmann, P., Beuscher, H.U. et al. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and la expression. Eur. J. Immunol. 1990, 20, 63-68